Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 31, Issue 6, Pages 906-914
Publisher
Wiley
Online
2016-04-04
DOI
10.1002/mds.26591
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurodegenerative CSF markers in genetic and sporadic PD: Classification and prediction in a longitudinal study
- (2015) Kathrin Brockmann et al. PARKINSONISM & RELATED DISORDERS
- Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
- (2014) Jan O. Aasly et al. Frontiers in Aging Neuroscience
- Protein phosphorylation in neurodegeneration: friend or foe?
- (2014) Sandra Tenreiro et al. Frontiers in Molecular Neuroscience
- Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism
- (2014) Jean-Marc Taymans et al. Frontiers in Genetics
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
- (2012) Brit Mollenhauer et al. NEUROSCIENCE LETTERS
- CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease
- (2011) Michael R. Sierks et al. Integrative Biology
- Induction of Intracellular Tau Aggregation Is Promoted by -Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
- (2011) E. A. Waxman et al. JOURNAL OF NEUROSCIENCE
- Amyloid-β and τ biomarkers in Parkinson's disease–dementia
- (2011) Mariateresa Buongiorno et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- CSF α-synuclein, tau, and amyloid β in Parkinson's disease
- (2011) Min Shi et al. LANCET NEUROLOGY
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
- (2011) Elisa Greggio et al. Molecular Neurodegeneration
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function
- (2011) Min Shi et al. NEUROBIOLOGY OF AGING
- Cerebrospinal fluid amyloid and tau in LRRK2 mutation carriers
- (2011) J. O. Aasly et al. NEUROLOGY
- Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson’s disease susceptibility?
- (2011) Joanna M. Biernacka et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- When does Parkinson's disease begin?
- (2010) Carles Gaig et al. MOVEMENT DISORDERS
- Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes
- (2010) Sigurd D. Süssmuth et al. MOVEMENT DISORDERS
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started